Interestingly, the absence of significant associations between NOS3 SNPs and therapeutic response in this study contrasts the findings in other cancers, where NOS3 polymorphisms have been shown to influence treatment outcomes or prognosis. The gene discussed is NOS3; the disease is cancer.